anti-c-fos Oncoprotein antibody product blog
Tags: Antibody; Polyclonal Antibody; c-fos Oncoprotein; anti-c-fos Oncoprotein antibody;
The c-fos Oncoprotein n/a (Catalog #MBS612565) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The c-fos Oncoprotein (Fos) reacts with Bovine, Feline, Porcine and may cross-react with other species as described in the data sheet. MyBioSource\'s c-fos Oncoprotein can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB).Suitable for use in Western Blot.
Dilution: Western Blot: 1-3ug/ml. Researchers should empirically determine the suitability of the c-fos Oncoprotein n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
The c-Fos oncoprotein is a member of the AP-1 family of transcription factors, which includes other Fos-related (FosB, Fra-1, Fra-2) and Jun-related (c-Jun, Jun B, Jun D) proteins. The downstream effects of c-Fos induction are numerous and in addition to roles in proliferation, transformation and apoptosis, c-Fos has been implicated in the differentiation of several cell.
Immunogen: Synthetic peptide derived from the C-terminal region of human c-Fos. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing c-fos Oncoprotein are readily searchable from our website. Different antibodies against the same target such as c-fos Oncoprotein may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.